Call for Abstract

4th International congress on Infectious Diseases, will be organized around the theme “Exploring recent outbreaks, advances & technologies in treatment & research of Infectious Diseases”

Infection Congress 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Infection Congress 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Infectious agents
  • Track 1-2Prevention and Treatment Therapies
  • Track 1-3Different Theoretical Approaches to the Immune system
  • Track 1-4Disorders of Human Immunity
  • Track 1-5Immune Deficiency Diseases
  • Track 1-6Immune Mechanisms
  • Track 1-7Routes of Infection Transmission and Transmissible Diseases
  • Track 1-8Opportunistic pathogens
  • Track 1-9Infectious diseases and clinical symptoms
  • Track 1-10Historic pandemics
  • Track 2-1Genetics of microbes and Related issues
  • Track 2-2Application of Microbial genetics
  • Track 2-3Pathophysiology
  • Track 2-4Anatomic locations of infection
  • Track 2-5Correlation of Host and Microbial metabolisms
  • Track 2-6Microbial defense mechanisms
  • Track 2-7Host immune mechanisms and response to microbial infections
  • Track 2-8Vectorborne Infections
  • Track 2-9Zoonotic Infections
  • Track 3-1Microbial Contamination in Counterfeit Medications
  • Track 3-2Recent outbreaks of infections from Contaminated pharmaceuticals
  • Track 3-3Microbial cultivable contaminations
  • Track 3-4Potential threats associated with Contaminated Pharmaceuticals
  • Track 3-5Physical or immunological barriers to infection
  • Track 3-6Inconsistent doses of active pharmaceutical
  • Track 3-7Pharmacopoeial limits
  • Track 4-1Recent outbreaks of food and water borne diseases
  • Track 4-2Bacterial, parasitic and viral infections
  • Track 4-3Epidemiology
  • Track 4-4Common causes and symptoms
  • Track 4-5Prevention and treatment methods
  • Track 4-6New approaches of diagnosis techniques
  • Track 4-7Preventable vaccines
  • Track 5-1Acute Respiratory Syndrome Coronavirus (SARS-CoV)
  • Track 5-2Porcine Epidemic Diarrhea Virus (PEDV)
  • Track 5-3Epidemics of human coronaviruses
  • Track 5-4Healthcare-associated outbreaks
  • Track 5-5Histopathology and Immunopathogenesis
  • Track 5-6Prevention and control measures of future Coronaviruses pandemics
  • Track 6-1Common types of Hospital and Community Acquired Infections
  • Track 6-2Environment factors responsible for contamination and transmission
  • Track 6-3Antimicrobial Resistance
  • Track 6-4Potential preventable conditions
  • Track 6-5Infection control precautions in patient care
  • Track 6-6Nosocomial infections surveillance & strategies
  • Track 7-1Recent pediatric food borne infections outbreaks
  • Track 7-2Pediatric infectious diseases
  • Track 7-3Maternal Infections
  • Track 7-4Infections of new born infant
  • Track 7-5Immunization
  • Track 8-1Causes and Symptoms
  • Track 8-2Pathophysiology of different Hemorrhagic fevers
  • Track 8-3Diagnosis techniques with advanced Bio-containment capabilities
  • Track 8-4Outbreaks of Hemorrhagic fevers
  • Track 8-5Prevention and Control
  • Track 8-6Antimicrobial Therapies
  • Track 9-1Diagnosis perplexing
  • Track 9-2Innovative diagnostic tools for Multidrug Resistance Pathogens
  • Track 9-3Immunodiagnostic assays
  • Track 9-4Rapid medical diagnostic methods
  • Track 9-5Conceived and Designed experiments
  • Track 9-6Diagnostic approach and implications for infection control
  • Track 10-1Parkinson disease
  • Track 10-2Laboratory studies on therapeutic interventions
  • Track 10-3Clinical Research
  • Track 10-4Translational Medicine
  • Track 10-5Trends in advanced research and therapies
  • Track 11-1Antimicrobial resistance mechanisms
  • Track 11-2Trends in Antimicrobial Resistance
  • Track 11-3Standard treatment methods for antimicrobial infections
  • Track 11-4Antimicrobial resistance diagnostic challenge
  • Track 11-5Vital role to fight against antimicrobial resistance
  • Track 12-1Historic pandemics
  • Track 12-2Emerging and Re-emerging diseases
  • Track 13-1Biotransformation of Drugs
  • Track 13-2Microbial effects on drug metabolism
  • Track 14-1Tuberculosis and Respiratory Diseases
  • Track 14-2Improved screening Techniques
  • Track 14-3Developing new drugs and diagnostic tests
  • Track 14-4Achievements and Challenges
  • Track 14-5Preventive measures